1. Home
  2. KNSA vs RUM Comparison

KNSA vs RUM Comparison

Compare KNSA & RUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • RUM
  • Stock Information
  • Founded
  • KNSA 2015
  • RUM 2013
  • Country
  • KNSA United Kingdom
  • RUM United States
  • Employees
  • KNSA N/A
  • RUM N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • RUM Computer Software: Prepackaged Software
  • Sector
  • KNSA Health Care
  • RUM Technology
  • Exchange
  • KNSA Nasdaq
  • RUM Nasdaq
  • Market Cap
  • KNSA 1.7B
  • RUM 1.7B
  • IPO Year
  • KNSA 2018
  • RUM N/A
  • Fundamental
  • Price
  • KNSA $21.09
  • RUM $6.42
  • Analyst Decision
  • KNSA Strong Buy
  • RUM Hold
  • Analyst Count
  • KNSA 5
  • RUM 2
  • Target Price
  • KNSA $36.60
  • RUM $8.00
  • AVG Volume (30 Days)
  • KNSA 365.7K
  • RUM 4.1M
  • Earning Date
  • KNSA 10-29-2024
  • RUM 11-12-2024
  • Dividend Yield
  • KNSA N/A
  • RUM N/A
  • EPS Growth
  • KNSA N/A
  • RUM N/A
  • EPS
  • KNSA N/A
  • RUM N/A
  • Revenue
  • KNSA $384,098,000.00
  • RUM $85,651,775.00
  • Revenue This Year
  • KNSA $60.05
  • RUM $30.64
  • Revenue Next Year
  • KNSA $36.32
  • RUM $22.88
  • P/E Ratio
  • KNSA N/A
  • RUM N/A
  • Revenue Growth
  • KNSA 54.41
  • RUM 6.36
  • 52 Week Low
  • KNSA $15.52
  • RUM $3.33
  • 52 Week High
  • KNSA $28.15
  • RUM $9.20
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 34.36
  • RUM 56.86
  • Support Level
  • KNSA $20.41
  • RUM $5.25
  • Resistance Level
  • KNSA $21.55
  • RUM $6.35
  • Average True Range (ATR)
  • KNSA 0.87
  • RUM 0.54
  • MACD
  • KNSA -0.14
  • RUM -0.02
  • Stochastic Oscillator
  • KNSA 21.90
  • RUM 57.35

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About RUM Rumble Inc.

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: